The histone demethylase KDM4D promotes hepatic fibrogenesis by modulating Toll-like receptor 4 signaling pathway

被引:32
作者
Dong, Fangyuan [1 ,3 ,4 ]
Jiang, Shuheng [2 ]
Li, Jun [2 ]
Wang, Yahui [2 ]
Zhu, Lili [2 ]
Huang, Yiqin [1 ,3 ,4 ]
Jiang, Xin [1 ,3 ,4 ]
Hu, Xiaona [1 ,3 ,4 ]
Zhou, Qi [5 ]
Zhang, Zhigang [2 ]
Bao, Zhijun [1 ,3 ,4 ]
机构
[1] Fudan Univ, Shanghai Med Coll, Huadong Hosp, Dept Gastroenterol, 221 Yanan West Rd, Shanghai 200040, Peoples R China
[2] Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst, Ren Ji Hosp,Sch Med, 800 Dongchuan Rd, Shanghai 200240, Peoples R China
[3] Shanghai Key Lab Clin Geriatr Med, Shanghai 200040, Peoples R China
[4] Fudan Univ, Res Ctr Aging & Med, Shanghai 200040, Peoples R China
[5] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Gastroenterol, Tongji Hosp, Wuhan 430030, Hubei, Peoples R China
关键词
JMJD2D; JHDM3D; Lysine demethylase 4D; KMT; KDM; NF-KAPPA-B; JMJD2; FAMILY; ACTIVATION; RECRUITMENT; METHYLATION; EZH2; CELL;
D O I
10.1016/j.ebiom.2018.11.055
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Accumulating evidence has revealed the pivotal role of epigenetic regulation in the pathogenesis of liver disease. However, the epigenetic mechanism that accounts for hepatic stellate cells (HSCs) activation in liver fibrosis remains largely unknown. Methods: Primary HSCs were used to screen the differentially expressed histone H3 lysine methyltransferases and demethylases during HSC activation. Loss-of-function experiments were applied to determine the cellular functions of KDM4D in HSCs. Transcriptome analysis was applied to explore the downstream targets of KDM4D. Real-time qPCR, western blotting, immunohistochemical staining, and chromatin immunoprecipitation were performed to uncover the underlying mechanism concerning KDM4D during liver fibrogenesis. Findings: KDM4D was identified as a remarkable up-regulated histone H3 demethylase during HSC activation. The overexpression profile of KDM4D was confirmed in three fibrosis animal models and human fibrotic liver tissues. In vitro Kdm4d knockdown impaired the collagen gel contraction and migration capacity of primary HSCs. In established CCl4-induced mice model, Kdm4d knockdown inhibited fibrosis progression, and promoted fibrosis reversal, with enhanced thinning and splitting of fibrotic septa, as well as a dramatic decrease in collagen area. Whole gene transcriptome analysis showed the regulatory role of KDM4D in Toll-Like Receptor (TLR) signaling pathway. Mechanistically, KDM4D catalyzed histone 3 on lysine 9 (H3K9) di-, and tri-demethylation, which promoted TLR4 expression, and subsequently prompted liver fibrogenesis by activating NF-kappa B signaling pathways. Interpretation: KDM4D facilitates TLR4 transcription through demethylation of H3K9, thus activating TLR4/NF-kappa B signaling pathways in HSCs, contributing to HSC activation and collagen crosslinking, further, hepatic fibrosis progression. Fund: Shanghai New Hundred Talents Program, Shanghai Municipal Commission of Health and Family Planning, Key Developing Disciplines Program, Shanghai Key disciplines program of Health and Family Planning and Shanghai Sailing Program. (c) 2018 Published by Elsevier B.V.
引用
收藏
页码:472 / 483
页数:12
相关论文
共 35 条
[1]   Mutant MMP-9 and HGF Gene Transfer Enhance Resolution of CCl4-Induced Liver Fibrosis in Rats: Role of ASH1 and EZH2 Methyltransferases Repression [J].
Atta, Hussein ;
El-Rehany, Mahmoud ;
Hammam, Olfat ;
Abdel-Ghany, Hend ;
Ramzy, Maggie ;
Roderfeld, Martin ;
Roeb, Elke ;
Al-Hendy, Ayman ;
Raheim, Salama Abdel ;
Allam, Hatem ;
Marey, Heba .
PLOS ONE, 2014, 9 (11)
[2]   Liver fibrosis [J].
Bataller, R ;
Brenner, DA .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (02) :209-218
[3]   EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid Transformation [J].
Beguelin, Wendy ;
Popovic, Relja ;
Teater, Matt ;
Jiang, Yanwen ;
Bunting, Karen L. ;
Rosen, Monica ;
Shen, Hao ;
Yang, Shao Ning ;
Wang, Ling ;
Ezponda, Teresa ;
Martinez-Garcia, Eva ;
Zhang, Haikuo ;
Zheng, Yupeng ;
Verma, Sharad K. ;
McCabe, Michael T. ;
Ott, Heidi M. ;
Van Aller, Glenn S. ;
Kruger, Ryan G. ;
Liu, Yan ;
McHugh, Charles F. ;
Scott, David W. ;
Chung, Young Rock ;
Kelleher, Neil ;
Shaknovich, Rita ;
Creasy, Caretha L. ;
Gascoyne, Randy D. ;
Wong, Kwok-Kin ;
Cerchietti, Leandro ;
Levine, Ross L. ;
Abdel-Wahab, Omar ;
Licht, Jonathan D. ;
Elemento, Olivier ;
Melnick, Ari M. .
CANCER CELL, 2013, 23 (05) :677-692
[4]   Histone Lysine Methylation Dynamics: Establishment, Regulation, and Biological Impact [J].
Black, Joshua C. ;
Van Rechem, Capucine ;
Whetstine, Johnathan R. .
MOLECULAR CELL, 2012, 48 (04) :491-507
[5]   Epidemiology of primary liver cancer [J].
Bosch, FX ;
Ribes, J ;
Borràs, J .
SEMINARS IN LIVER DISEASE, 1999, 19 (03) :271-285
[6]   S100A4 promotes liver fibrosis via activation of hepatic stellate cells [J].
Chen, Lin ;
Li, Jie ;
Zhang, Jinhua ;
Dai, Chengliang ;
Liu, Xiaoman ;
Wang, Jun ;
Gao, Zhitao ;
Guo, Hongyan ;
Wang, Rui ;
Lu, Shichun ;
Wang, Fusheng ;
Zhang, Henghui ;
Chen, Hongsong ;
Fan, Xiaolong ;
Wang, Shengdian ;
Qin, Zhihai .
JOURNAL OF HEPATOLOGY, 2015, 62 (01) :156-164
[7]   Structural insights into histone demethylation by JMJD2 family members [J].
Chen, Zhongzhou ;
Zang, Jianye ;
Whetstine, Johnathan ;
Hong, Xia ;
Davrazou, Foteini ;
Kutateladze, Tatiana G. ;
Simpson, Michael ;
Mao, Qilong ;
Pan, Cheol-Ho ;
Dai, Shaodong ;
Hagman, James ;
Hansen, Kirk ;
Shi, Yang ;
Zhang, Gongyi .
CELL, 2006, 125 (04) :691-702
[8]   A central role for G9a and EZH2 in the epigenetic silencing of cyclooxygenase-2 in idiopathic pulmonary fibrosis [J].
Coward, William R. ;
Feghali-Bostwick, Carol A. ;
Jenkins, Gisli ;
Knox, Alan J. ;
Pang, Linhua .
FASEB JOURNAL, 2014, 28 (07) :3183-3196
[9]   Clinical evidence for the regression of liver fibrosis [J].
Ellis, Elizabeth L. ;
Mann, Derek A. .
JOURNAL OF HEPATOLOGY, 2012, 56 (05) :1171-1180
[10]   Mechanisms of hepatic fibrogenesis [J].
Friedman, Scott L. .
GASTROENTEROLOGY, 2008, 134 (06) :1655-1669